Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD
Update: 2025-08-22
Description
Using biomarker testing and APOE genotyping to determine patient eligibility for amyloid-targeting therapies.
Credit available for this activity expires: 8/19/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002844?ecd=bdc_podcast_libsyn_mscpedu
Comments
In Channel